LOS ANGELES--(BUSINESS WIRE)--Aug. 15, 2005--St. Paul Pharmaceutical, a pending merger partner with WENR Corp. (OTC:WNRC) (wenr.net), announced today that it is expanding its marketing of probiotic products to the Canadian, Central and South American markets.
